Studieoverzicht - 2022-04 NABOR

 
Number 2022-04 NABOR
Nickname NABOR
Status In preparation Date: 11-03-2022
Inclusion closed
Other study number(s)
Participating parties/groups IKNL-UT-NIVEL
Full title Effectiveness of persoNalized care After treatment for non-metastasized Breast cancer based On risk of Recurrence, personal needs and risk on (late) health effects: the NABOR study.
Phase and type Other
Age ≥18
Menopausal status Not applicable
Indication Data registration
Subindication Not applicable
Target sample size 1040
Actual accrual Date: 11-03-2022
Estimated study completion date
CCMO approval Not applicable Date: Nr:
EudraCT nr.
Trial Register
METC approval Not applicable Date: METC: Nr:
Amendments Date:
KWF-CKS approval Date: Nr:
News item
Website https://www.zonmw.nl/nl/onderzoek-resultaten/doelmatigheidsonderzoek/programmas/project-detail/evaluatieonderzoek-zegg/effectiveness-of-personalized-care-after-treatment-for-non-metastasized-breast-cancer-based-on-risk/
Sponsor IKNL
Principal Investigator(s) Prof. dr. S. Siesling (IKNL, UT), dr. J.C. Korevaar (NIVEL)
Study manager Anneleen Klaassen-Dekker; e-mail: NABOR@iknl.nl
Central datamanagement and randomization
Monitoring
Local datamanagement
Funding
Extra

Design:
Objectives:
Endpoints:
Main eligibility criteria:
Documents (public):
Documents (protected):
In order to see this content you need to be logged on.

Login.

Back